ANUBIS PHARMA LIMITED
25 ECCLESTON PLACE, ECCLESTON YARDS, LONDON  SW1W 9NF- Active - Proposal to Strike off
- Private Limited Company
- Company No. 12266533
- Last Updated: 01 Mar 2024
Company Profile
ANUBIS PHARMA LIMITED was incorporated on Wednesday, October 16, 2019 as a Private Limited Company with registered address in LONDON. ANUBIS PHARMA LIMITED has the status: Active - Proposal to Strike off and it's listed in the following category: Management consultancy activities other than financial management. This Private Limited Company has been operating for 5 years 4 months and 8 days.
Name | ANUBIS PHARMA LIMITED |
---|---|
Company number | 12266533 |
Company type | Private Limited Company |
Incorporation date | 16 Oct 2019 |
Status | Active - Proposal to Strike off |
Industry (SIC 2007) |
Address
Registered Address |
25 ECCLESTON PLACE ECCLESTON YARDS LONDON SW1W 9NF |
---|---|
Country Of Origin | ENGLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mr Anthony Neville Chisholm Eastman Nationality: Australian |
Dates: Wednesday, October 16, 2019 - Wednesday, April 8, 2020
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Mr Roby Reuven Zomer Nationality: Israeli |
Dates: Wednesday, October 16, 2019 - Wednesday, April 8, 2020
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Accounts and Confirmation
Type of accounts | MICRO ENTITY |
---|---|
End of financial Year | 31 October |
Next annual accounts due | 31 July 2022, (-939 days left) |
Latest accounts | 31 October 2020 |
Next confirmation statement due | 13 November 2020 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against ANUBIS PHARMA LIMITED.
Previous Names
Name | Change Date |
---|---|
ANUBIS PHARMA LIMITED | 16 Oct 2019 |
MERCURY PHARMA LIMITED | 10 Feb 2020 |